Inactive Instrument

Calendar AspenBio Pharma, Inc. Nasdaq

Equities

US0453462022

End-of-day quote Nasdaq
- USD - Intraday chart for AspenBio Pharma, Inc.

Chart calendar AspenBio Pharma, Inc.

ab17b852324f5b980cdc5044b5b6d.nDgU4PH-TkfLIaKmAILc2zC0uNP26gqzjOusbboLXyQ.zXB3uZy9NBSYFcfCM8G5iwbX9ISkgFrpxK-ZW-h4Gkb3Z3fNhpF7H6lulg~fc3a711591a8a69a3e82d2698b071d47

Upcoming events on AspenBio Pharma, Inc.

2024-04-30 Q1 2024 Earnings Release
2024-05-01 08:30 am Q1 2024 Earnings Call
2024-06-12 10:00 am Annual General Meeting
2024-08-18 Q2 2024 Earnings Release (Projected)
2024-11-04 Q3 2024 Earnings Release (Projected)
2025-03-11 Q4 2024 Earnings Release (Projected)

Past events on AspenBio Pharma, Inc.

2024-03-19 12:30 pm Roth Conference
2024-03-05 09:00 am February 2024 Sales and Revenue Release - Production Update
2024-02-22 04:45 pm Q4 2023 Earnings Release
2024-02-05 09:00 am January 2024 Sales and Revenue Release - Production Update
2024-01-18 11:45 am Needham Growth Conference
2023-12-14 11:00 am Extraordinary Shareholders Meeting
2023-12-12 Roth MKM Deer Valley Conference
2023-12-07 12:00 pm Singular Research Best of the Uncovered Conference
2023-12-06 09:00 am November 2023 Sales and Revenue Release - Production Update
2023-11-27 Wells Fargo TMT Summit
2023-11-14 North American Blockchain Summit
2023-11-14 ROTH MKM New York Technology Conference
2023-11-07 05:26 pm Q3 2023 Earnings Release
2023-11-07 04:45 pm October 2023 Sales and Revenue Release - Production Update
2023-10-29 AIM Summit
2023-10-11 Bitcoin Conference
2023-10-04 Pacific Bitcoin Conference
2023-10-04 04:45 pm September 2023 Sales and Revenue Release - Production Update
2023-09-18 Northland Capital Markets Institutional Investor Conference
2023-09-10 H.C. Wainwright Global Investment Conference

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
6,84


12,1
10,4
16.16%
213
211
1.02%
259
255
1.82%
281
288
-2.67%

493

EBITDA
Million USD
Released
Forecast
Spread
0,00


0,00
0,00
-
82,4
126
-34.56%
-67,2
-49,8
-34.85%
214
79,1
170.56%

184

EBIT
Million USD
Released
Forecast
Spread
0,00


-19,3
-22,3
13.38%
-22,4
41,1
-154.45%
-457
-371
-23.21%
-63,0
-190
66.86%

-157

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
0,00


-12,7
-20,4
37.91%
-7,67
38,8
-119.8%
-521
-377
-38.11%
-54,6
-203
73.08%

-134

Net income
Million USD
Released
Forecast
Spread
0,00


-12,7
-20,3
37.44%
-7,93
35,7
-122.21%
-510
-394
-29.38%
-49,5
-185
73.26%

-141

EPS
USD
Released
Forecast
Spread
-1,02


-0,30
-0,51
41.18%
-0,08
0,36
-122.53%
-3,65
-2,80
-30.42%
-0,28
-0,97
71.19%

-0,53

Announcement Date25/03/2031/03/2116/03/2202/03/2322/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD
Released
Forecast
Spread
90,8
89,4
1.63%
79,8
81,8
-2.42%
72,9
74,2
-1.74%
46,3
55,5
-16.64%
60,1
55,5
8.34%
73,2
76,6
-4.48%
76,7
84,0
-8.61%
51,9
65,7
-21.01%
78,8
84,6
-6.81%

94,5


103


127


162


203

EBITDA
Million USD
Released
Forecast
Spread

57,1

11,7
34,8
-66.26%
-65,2
19,7
-431.01%
0,17
19,8
-99.16%
-13,9
3,44
-504.77%
7,50
11,6
-35.39%
24,0
23,8
0.79%
31,6
21,0
50.1%
151
16,4
820.23%

27,1


31,5


56,6


72,7


106

EBIT
Million USD
Released
Forecast
Spread
-33,9
29,2
-216%
37,9
-8,20
562.53%
-366
3,22
-11469.79%
-40,0
-4,74
-743.83%
-103
-27,1
-280.27%
-56,8
-22,4
-153.56%
-32,5
-32,8
0.88%
-47,8
-36,5
-30.91%
74,1
-55,6
233.34%

-42,0


-53,7


-31,6


-26,2


38,8

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-22,9
26,1
-187.95%
35,9
4,42
713.33%
-373
3,29
-11437.56%
-39,5
-4,21
-838.43%
-159
-26,5
-499.74%
-60,7
-27,1
-124.15%
-27,6
-35,8
23.08%
-45,5
-41,2
-10.32%
79,1
-56,8
239.47%

-42,9


-46,9


-24,6


-18,5


38,8

Net income
Million USD
Released
Forecast
Spread
-19,5
23,6
-182.29%
35,6
3,97
797.77%
-366
2,31
-15959.58%
-36,6
-4,39
-733.91%
-156
-26,2
-494.77%
-55,7
-26,7
-108.6%
-27,7
-35,3
21.52%
-45,3
-41,0
-10.62%
79,2
-55,8
241.94%

-44,8


-46,7


-27,2


-20,4


12,1

EPS
USD
Released
Forecast
Spread
-0,21
0,21
-202.09%
0,30
0,01
4397.75%
-2,81
0,02
-15231.93%
-0,24
-0,03
-734.78%
-1,01
-0,16
-531.25%
-0,33
-0,17
-98%
-0,17
-0,21
17.07%
-0,25
-0,23
-7.2%
0,48
-0,29
268.09%

-0,21


-0,20


-0,11


-0,08


0,16

Announcement Date16/03/2210/05/2215/08/2207/11/2202/03/2310/05/2309/08/2308/11/2322/02/24-----
  1. Stock Market
  2. Equities
  3. RIOT Stock
  4. Stock
  5. Calendar AspenBio Pharma, Inc.